Manorama Industries Ltd

On a year on year basis, the company's net profit jumped 40.82% while revenue from operations climbed 64.21% in Q4 FY26. The revenue growth fuelled by a favourable product mix of value-added products, complemented by higher utilization from the enhanced fractionation capacity. Profit before tax (PBT) rose 47.98% YoY to Rs 80.81 crore in Q4 FY26. EBITDA stood at Rs 1028.5 crore, up 61% compared with Rs 639 crore in Q4 FY25. EBITDA margin contracted 54 bps to 26.9% in Q4 FY26 as against 27.4% in Q4 FY25. On a full year basis, the company's standalone net profit surged 108.13% to Rs 233.21 crore on 76.13% rise in revenue from operations to Rs 1357.69 crore in FY26 over FY25. For FY26, the domestic to export revenue mix and stood at 43:57, reflecting diversified market presence. Chairman and managing director of Manorama Industries, said, 'Manorama Industries has once again delivered a sustainable performance during FY26. The company achieved revenues of Rs 1,358 crore, reflecting a year-on-year growth of 76.1%. This underscores the sustainable demand for our products across the Food and cosmetics sectors, as well as the strength of our integrated value chain. By the end of FY26, we boosted the capacity of our Solvent Fractionation Plant 2 (SF 2) by 30%, increasing it from 25,000 to 32,500 tonnes per annum through debottlenecking. We plan to implement similar capacity enhancements for Solvent Fractionation Plant 1 (SF 1), currently at 15,000 TPA. These expansions will enable us to meet the demand for Speciality fats and butters. As we look ahead, we aim to further strengthening our leadership position through planned strategic capex of approx Rs 460 crore over the next 2-3 years. This includes investments in forward and backward integration, a new manufacturing facility for cocoa butter alternatives, refinery expansion and the establishment of a processing plant in Burkina Faso. Through these initiatives we aim to diversify raw material sources, enhance global competitiveness and support long-term sustainable growth.' Meanwhile, the company's board recommended the final dividend of Rs 0.80 per equity share with a face value of Rs 2 each for the financial year 2025-26. Additionally, the board approved a proposal to support the setting up of a processing facility in Burkina Faso through its wholly owned subsidiary, Taang Kaam Industries SA, through one or more financial assistance arrangements. These include an increase in share capital/equity investment of up to Rs 150 crore, unsecured loans of up to Rs 100 crore, and corporate guarantees, bank guarantees and/or standby letters of credit (SBLCs) aggregating up to Rs 100 crore on behalf of the subsidiary. Manorama Industries (MIL) is a global pioneer in manufacturing speciality fats & butters and exotic products. The company has carved a niche in manufacturing Sal CBE & Stearin, Shea CBE & Stearin, Mango CBE & Stearin and other exotic fats & butter. MIL offers customized solutions to companies in chocolate, confectionery and cosmetic industry. Powered by Capital Market - Live

Manorama Industries announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the final dividend of Rs 0.8 per equity Share (i.e. 40%) , subject to the approval of the shareholders.

Net profit of Manorama Industries rose 6.09% to Rs 42.48 crore in the quarter ended March 2026 as against Rs 40.04 crore during the previous quarter ended March 2025. Sales rose 68.09% to Rs 391.34 crore in the quarter ended March 2026 as against Rs 232.81 crore during the previous quarter ended March 2025. For the full year,net profit rose 95.77% to Rs 214.94 crore in the year ended March 2026 as against Rs 109.79 crore during the previous year ended March 2025. Sales rose 77.31% to Rs 1366.74 crore in the year ended March 2026 as against Rs 770.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales391.34232.81 68 1366.74770.84 77 OPM %21.6226.31 -25.7124.18 - PBDT71.0358.81 21 323.84168.22 93 PBT63.6052.41 21 298.18146.08 104 NP42.4840.04 6 214.94109.79 96 Powered by Capital Market - Live

Manorama Industries will hold a meeting of the Board of Directors of the Company on 11 May 2026.

The fundraising may be undertaken through qualified institutional placement (QIP) or any other permissible mode, subject to the approval of shareholders and other regulatory or statutory approvals, as may be required. Manorama Industries (MIL) is a global pioneer in the manufacturing of cocoa butter equivalent (CBE), specialty fats & butters, and exotic products. The company has carved a niche in manufacturing Sal CBE & Stearin, Shea CBE & Stearin, Mango CBE & Stearin, and other exotic fats & butter. MIL offers customized solutions to Fortune 500 companies in the chocolate, confectionery, and cosmetic industries. The company reported a 137.18% surge in consolidated net profit to Rs 72.27 crore on a 73.3% increase in net sales to Rs 362.54 crore in Q3 FY26 over Q3 FY25. The scrip shed 0.51% to close at Rs 1,327.65 on the BSE.Powered by Capital Market - Live

Manorama Industries will hold a meeting of the Board of Directors of the Company on 12 March 2026.Powered by Capital Market - Live

Manorama Industries will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live

Net profit of Manorama Industries rose 105.47% to Rs 54.88 crore in the quarter ended September 2025 as against Rs 26.71 crore during the previous quarter ended September 2024. Sales rose 65.44% to Rs 323.31 crore in the quarter ended September 2025 as against Rs 195.42 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales323.31195.42 65 OPM %27.1223.13 - PBDT80.5440.91 97 PBT74.4935.30 111 NP54.8826.71 105 Powered by Capital Market - Live

Manorama Industries will hold a meeting of the Board of Directors of the Company on 17 October 2025.Powered by Capital Market - Live

Manorama Industries has allotted 94,480 equity shares under ESOP on 05 September 2025. With this allotment, the paid up equity share capital has increased to Rs. 11,94,17,060/- dividend into 597,08,530 equity shares of face value of Rs 2 each. Powered by Capital Market - Live